Advertisement
Screener

INNOVIVA, INC. (INVA) ROE

INNOVIVA, INC. (INVA) ROE

  • 2026-06-30: ROE 28.97%.
  • 2026-03-31: ROE 37.59%.
  • 2025-12-31: ROE 23.12%.
  • 2025-09-30: ROE 12.61%.

Complete source-backed roe history.

Available history
2012-03-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3028.97%
2026-03-3137.59%
2025-12-3123.12%
2025-09-3012.61%
2025-06-305.41%
2025-03-31-9.23%
2024-12-313.38%
2024-09-309.66%
2024-06-3021.85%
2024-03-3125.78%
2023-12-3126.63%
2023-09-307.95%
2023-06-3035.52%
2023-03-3138.69%
2022-12-3138.93%
2022-09-3052.11%
2022-06-3053.44%
2022-03-3176.82%
2021-12-3188.93%
2021-09-3098.86%
2021-06-30102.24%
2021-03-3151.15%
2020-12-3154.42%
2020-09-3056.98%
2020-06-3061.74%
2020-03-3160.58%
2019-12-3160.92%
2019-09-30150.66%
2019-06-30178.87%
2019-03-31221.00%
2018-12-31264.57%
2018-09-30-175.68%
2018-06-30-107.54%
2018-03-31-69.19%
2017-12-31-55.29%
2017-09-30-45.40%
2017-06-30-27.60%
2017-03-31-10.80%
2016-12-31-29.42%
2016-03-31-14.73%
2015-03-31-10.08%
2012-03-31262.21%

Annual ROE

DateROE
2025-12-3123.12%
2024-12-313.38%
2023-12-3126.63%
2022-12-3138.93%
2021-12-3188.93%
2020-12-3154.42%
2019-12-3160.92%
2018-12-31264.57%
2017-12-31-55.29%
2016-12-31-16.87%
2015-12-315.48%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10